✦ LIBER ✦

Immune escape as a fundamental trait of cancer: focus on IDO

✍ Scribed by Prendergast, G C

Book ID: 109970679
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 354 KB
Volume: 27
Category: Article
ISSN: 0950-9232
DOI: 10.1038/onc.2008.35

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Indoleamine-2,3 dioxygenase (IDO) expres

Indoleamine-2,3 dioxygenase (IDO) expression as a mechanism of immune escape by basal cell carcinoma

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB

[Focus on Biotechnology] Fundamentals of

[Focus on Biotechnology] Fundamentals of Cell Immobilisation Biotechnology Volume 8A || Starches as Encapsulation Materials

✍ Nedović, Viktor; Willaert, Ronnie 📂 Article 📅 2004 🏛 Springer Netherlands ⚖ 951 KB

980 A randomized phase 2 study evaluatin

980 A randomized phase 2 study evaluating the optimal sequencing of sipuleucel-T and androgen deprivation therapy (ADT) in biochemically-recurrent prostate cancer (BRPC): Immune results with a focus on humoral responses

✍ Antonarakis, E.S.; Kibel, A.S.; Adams, G.W.; Karsh, L.I.; Elfiky, A.; Shore, N.D 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 202 KB

2208 CAN A GLEASON 6 OR LESS MICRO-FOCUS

2208 CAN A GLEASON 6 OR LESS MICRO-FOCUS OF PROSTATE CANCER IN ONE BIOPSY AND PROSTATE SPECIFIC ANTIGEN LEVEL < 10 NG/ML BE DEFINED AS ARCHETYPE OF LOW-RISK PROSTATE DISEASE?

✍ Taverna, Gianluigi; Benecchi, Luigi; Grizzi, Fabio; Giusti, Guido; Seveso, Mauro 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 318 KB

Does [meso-1,2-bis(2,6-dichloro-4-hydrox

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]-dichloroplatinum (II) Act on the Hormone-Sensitive, Murine Breast Cancer as a Biological Response Modifier? Part II. Studies on the Influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) on the Specific Immune Defense in MXT-M-3,2 Breast Cancer Bearing Mice

✍ Richard Schlemmer; Thilo Spruß; Günther Bernhardt; Helmut Schönenberger 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 1 views

Faut-il faire une dérivation gastro-jéju

Faut-il faire une dérivation gastro-jéjunale prophylactique dans la chirurgie palliative du cancer du pancréas ? Résultats d’une étude contrôlée: N.T. Van Heek, S.M.M. De castro, C.H. Van Eijck, R.C.I. Van Geenen, E.J. Hesselink, P.J. Breslau, T.C. Khe Tran, G. Kazemier, M.R.M. Visser, O.R.C. Busch, H. Obertrop, D.J. Gouma The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer : a prospective randomized mulitcenter trial with special focus on assessment of quality of life Ann Surg 2003;238:894-905

✍ B. Dousset; Ph. de Mestier; C. Vons 📂 Article 📅 2004 🏛 Masson Editeur 🌐 French ⚖ 76 KB